Pharmacokinetics (PK) and pharmacodynamics (PD) of interferon β-1a in healthy volunteers.

被引：0
|
作者：
Buchwalder, PA
Buclin, T
Trinchard, I
Munafo, A
Biollaz, J
机构：
[1] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland
[2] Ares Serono, Geneva, Switzerland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI117
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [31] Impact of demographic and clinical factors on the pharmacokinetics (PK) of sunitinib in patients and healthy volunteers.
    Houk, B. E.
    Kang, D.
    Bello, C.
    Cohen, D.
    Poland, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S53 - S54
  • [32] Pharmacokinetics of PD 0200390 following multiple dose administration to healthy volunteers.
    Corrigan, B. W.
    Werth, J.
    Moton, A.
    Alvey, C.
    Feltner, D.
    Ouellet, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S30 - S30
  • [33] PK-PD relationship of the effects of argatroban on haemostasis in healthy young volunteers.
    Garrigou, D
    Dubruc, C
    Thuillez, C
    Bergougnan, L
    Thenot, JP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 151 - 151
  • [34] POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF ETRUMADENANT (AB928) IN HEALTHY VOLUNTEERS AND CANCER PATIENTS.
    Wu, H.
    Liao, K.
    Nguyen, L.
    Seitz, L.
    Jin, L.
    Criste, R.
    Wang, B.
    Agoram, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S57 - S57
  • [35] Population pharmacokinetics/pharmacodynamics (PK/PD) of UK-279,276 (NIF) in healthy volunteers and patients.
    Jonsson, EN
    MacIntyre, F
    James, I
    Wild, W
    Karlsson, MO
    Marshall, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P54 - P54
  • [36] PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING FOR METFORMIN IN HEALTHY VOLUNTEERS.
    Kim, Y.
    Cho, S.
    Lee, D.
    Son, H.
    Roh, H.
    Son, M.
    Heo, Y.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S48 - S48
  • [37] The effect of rifampin on the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban in healthy subjects
    Mendell, J.
    Chen, S.
    He, L.
    Desai, M.
    Parasrampuria, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 17 - 17
  • [38] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TEPOXALIN IN HEALTHY MALE-SUBJECTS
    WALDMAN, SA
    OSBORNE, B
    VITOW, C
    ARGENTIERI, D
    CHOW, A
    WONG, E
    SINGER, M
    LUI, N
    MISITI, J
    BJORNSSON, TD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 152 - 152
  • [39] STUDY ON PHARMACOKINETICS OF BIAPENEM IN HEALTHY VOLUNTEERS.
    Shen, Q.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S32 - S32
  • [40] Population pharmacokinetics of fentanyl in healthy volunteers.
    Ariano, RE
    Duke, P
    Sitar, DS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 153 - 153
12345